A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
Trial Summary
What is the purpose of this trial?
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
Research Team
Robert Vassallo, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Evaluation
Comprehensive clinical evaluation and symptom characterization, quantitative lung CT image analysis and pulmonary function testing, and quality of life questionnaires
Midpoint Evaluation
Continued assessment with clinical evaluations, imaging, and testing, including bronchoscopy with BAL and blood samples
Final Evaluation
Final comprehensive evaluation including bronchoscopy with BAL, blood samples, and quality of life assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor